This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Hematology/ Hematologic Malignancies  • Leukemias/ Lymphomas  • Alert me on articles by topic

Arch Dermatol. 2003;139:926-928.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

PATIENTS WITH cutaneous lymphoma present to dermatologists with malignant exaggerations of cutaneous lymphocyte biological features.¹ The puzzles presented by cutaneous T-cell lymphomas (CTCLs) are actively being pursued to understand and, one hopes, to exploit the regulation of cutaneous T cells. In the immunoregulatory repertoire of the skin are the answers to atopic dermatitis, psoriasis, contact sensitivity, and most inflammatory disorders that also present to dermatologists. The lure of understanding T-cell regulation by way of CTCL has even attracted criminal activities. One group of CTCL investigators was convicted of fraud when they uttered their version of "eureka."² Still, there are few shouts of discovery. The answers can only be achieved in a stepwise approach. The accompanying article by Kim et al³ is a fitting memorial to the extent of information available from retrospective observational studies of CTCL. The key points of that article lead us to visualize the next steps: the . . . [Full Text of this Article]

RELATED ARTICLE

Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome: Clinical Prognostic Factors and Risk for Disease Progression
Youn H. Kim, Howard L. Liu, Serena Mraz-Gernhard, Anna Varghese, and Richard T. Hoppe
Arch Dermatol. 2003;139(7):857-866.
ABSTRACT | FULL TEXT